Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Excitatory amino acid transporter 3 (EAAT3), encoded by the *SLC1A1* gene, is a major neuronal high-affinity sodium-dependent glutamate transporter found predominately in the plasma membrane of neurons[1][3][5][7][9]. EAAT3 is essential for clearing extracellular glutamate and terminating the postsynaptic effect of glutamate neurotransmission, thereby preventing neurotoxicity caused by excessive glutamate[3][4][5]. It is also the principal transporter for neuronal cysteine uptake, which is crucial for the synthesis of glutathione, a major antioxidant in neurons[1][3][5]. Loss or inhibition of EAAT3 leads to reduced antioxidant capacity, increased oxidative stress, and age-dependent neuronal loss[1][3]. EAAT3 interacts with various proteins (such as GTRAP3-18), and its function can be negatively regulated by alternative splicing and interacting proteins, adding complexity to its regulation[2][7]. Pathological changes in EAAT3 expression or function have been associated with several neurological and psychiatric diseases—including schizophrenia, epilepsy, multiple sclerosis, and obsessive-compulsive disorder—often through mechanisms involving glutamate excitotoxicity or impaired antioxidant defense[1][7][8][10]. EAAT3 may also have roles in cancer due to altered cysteine metabolism[8]. Experimental drugs/interventions that inhibit EAAT3 (such as DL-TBOA) demonstrate the importance of EAAT3 in maintaining neuronal health and function[2][3].
Inhibition of glutamate transport, Negative modulation via protein interaction (e.g., GTRAP3-18), Reduced cysteine/glutathione synthesis when inhibited
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Excitatory amino acid transporter 3 (EAAT3).